Traditional Chinese herbal medicines suppress endometriosis development through modulating macrophage-mediated immune responses in the peritoneal cavity

In: BioMedicine · 2026 · vol. 16(2) · doi:10.37796/2211-8039.1706 · W7162598003
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-08

Traditional Chinese herbal medicines Danggui Buxue Tang and Shaofu Zhuyu Tang modulate peritoneal macrophages, reduce endometriosis lesion growth and adhesion, and alleviate pain in a mouse model.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08

This paper studied four traditional Chinese herbal medicine (TCHM) formulae in a mouse model engineered to exhibit features resembling human endometriosis, assessing peritoneal immune responses, lesion growth, pain-associated behaviors, and adhesion formation. The authors found that Danggui Buxue Tang (DBT) and Shaofu Zhuyu Tang (SZT) increased peritoneal macrophage numbers with M1 phenotype polarization, and this macrophage activation was associated with restrained lesion formation, reduced chronic inflammation, and reduced nerve fiber growth; behavioral assays also showed pain-relief–related changes. DBT and SZT further downregulated adhesion molecules such as ICAM-1 and AKAP12 in lesions, corresponding to reduced endometriosis adhesion. The paper’s main limitation, as stated in its framing, is that it provides molecular evidence primarily from an animal model rather than direct clinical data. This paper is centrally about endometriosis — it examines how specific TCHM formulae modulate macrophage-mediated peritoneal immunity to suppress endometriosis development.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Due to unique dietary culture, Asian patients with endometriosis usually seek assistance through traditional Chinese herbal medicine (TCHM), making combined treatments of Western and Chinese medicine quite common in Asia. However, limited molecular evidence has been provided to demonstrate the therapeutic benefits of TCHM in treating endometriosis. Aims: To investigate the functional impacts of TCHM treatment in their traditional formulae on peritoneal immunity, lesion growth, and adhesion formation, we performed studies by using a disease mouse model that exhibits the features of blood stasis and stagnation. Methods: Four well-known TCHM formulae, frequently used for treating symptoms similar to endometriosis, were applied to a mouse model with human endometriosis features. Lesion growth, modulation of peritoneal immune responses, pain-associated behaviors, and endometriosis adhesion were analyzed after TCHM treatment. Results: Among the formulae, Danggui Buxue Tang (DBT) and Shaofu Zhuyu Tang (SZT) can promote blood circulation into the peritoneal cavity, resulting in increased large (LpMs) and small (SpMs) peritoneal macrophages with M1 phenotype polarization. Macrophage activation restrained lesion formation, chronic inflammation, and nerve fiber growth in the treated mice. Behavioral studies further confirmed pain-relief effects that enhanced spontaneous locomotor activity and reduced evoked mechanical hyperalgesia. Interestingly, DBT and SZT treatments can also downregulate the expression of key adhesion molecules, such as ICAM-1 and AKAP12, in the lesions, leading to reduced endometriosis adhesion in treated mice. Conclusion: These findings reveal the functional effects of TCHM formulae, especially DBT and SZT, on macrophage-mediated immune responses in the peritoneal cavity, which may benefit patients with endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-15T06:07:39.029377+00:00
License: CC0 · commercial use OK